These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

522 related items for PubMed ID: 9521728

  • 1. Structural basis for different inhibitory specificities of human cystatins C and D.
    Hall A, Ekiel I, Mason RW, Kasprzykowski F, Grubb A, Abrahamson M.
    Biochemistry; 1998 Mar 24; 37(12):4071-9. PubMed ID: 9521728
    [Abstract] [Full Text] [Related]

  • 2. Structural basis for the biological specificity of cystatin C. Identification of leucine 9 in the N-terminal binding region as a selectivity-conferring residue in the inhibition of mammalian cysteine peptidases.
    Hall A, Håkansson K, Mason RW, Grubb A, Abrahamson M.
    J Biol Chem; 1995 Mar 10; 270(10):5115-21. PubMed ID: 7890620
    [Abstract] [Full Text] [Related]

  • 3. Amino acid substitutions in the N-terminal segment of cystatin C create selective protein inhibitors of lysosomal cysteine proteinases.
    Mason RW, Sol-Church K, Abrahamson M.
    Biochem J; 1998 Mar 01; 330 ( Pt 2)(Pt 2):833-8. PubMed ID: 9480898
    [Abstract] [Full Text] [Related]

  • 4. Interaction of cystatin C variants with papain and human cathepsins B, H and L.
    Cimerman N, Prebanda MT, Turk B, Popovic T, Dolenc I, Turk V.
    J Enzyme Inhib; 1999 Mar 01; 14(2):167-74. PubMed ID: 10445041
    [Abstract] [Full Text] [Related]

  • 5. Importance of the evolutionarily conserved glycine residue in the N-terminal region of human cystatin C (Gly-11) for cysteine endopeptidase inhibition.
    Hall A, Dalbøge H, Grubb A, Abrahamson M.
    Biochem J; 1993 Apr 01; 291 ( Pt 1)(Pt 1):123-9. PubMed ID: 8471031
    [Abstract] [Full Text] [Related]

  • 6. Elongation on the amino-terminal part of stefin B decreases inhibition of cathepsin H.
    Jerala R, Kroon-Zitko L, Popovic T, Turk V.
    Eur J Biochem; 1994 Sep 15; 224(3):797-802. PubMed ID: 7925405
    [Abstract] [Full Text] [Related]

  • 7. Crystal structure of human cystatin D, a cysteine peptidase inhibitor with restricted inhibition profile.
    Alvarez-Fernandez M, Liang YH, Abrahamson M, Su XD.
    J Biol Chem; 2005 May 06; 280(18):18221-8. PubMed ID: 15728581
    [Abstract] [Full Text] [Related]

  • 8. The affinity and kinetics of inhibition of cysteine proteinases by intact recombinant bovine cystatin C.
    Olsson SL, Ek B, Björk I.
    Biochim Biophys Acta; 1999 Jun 15; 1432(1):73-81. PubMed ID: 10366730
    [Abstract] [Full Text] [Related]

  • 9. Grafting of features of cystatins C or B into the N-terminal region or second binding loop of cystatin A (stefin A) substantially enhances inhibition of cysteine proteinases.
    Pavlova A, Björk I.
    Biochemistry; 2003 Sep 30; 42(38):11326-33. PubMed ID: 14503883
    [Abstract] [Full Text] [Related]

  • 10. Importance of the second binding loop and the C-terminal end of cystatin B (stefin B) for inhibition of cysteine proteinases.
    Pol E, Björk I.
    Biochemistry; 1999 Aug 10; 38(32):10519-26. PubMed ID: 10441148
    [Abstract] [Full Text] [Related]

  • 11. Different forms of human cystatin C.
    Popović T, Brzin J, Ritonja A, Turk V.
    Biol Chem Hoppe Seyler; 1990 Jul 10; 371(7):575-80. PubMed ID: 2222856
    [Abstract] [Full Text] [Related]

  • 12. The contribution of N-terminal region residues of cystatin A (stefin A) to the affinity and kinetics of inhibition of papain, cathepsin B, and cathepsin L.
    Estrada S, Pavlova A, Björk I.
    Biochemistry; 1999 Jun 01; 38(22):7339-45. PubMed ID: 10353845
    [Abstract] [Full Text] [Related]

  • 13. Cathepsin L is capable of truncating cystatin C of 11 N-terminal amino acids.
    Popovic T, Cimerman N, Dolenc I, Ritonja A, Brzin J.
    FEBS Lett; 1999 Jul 16; 455(1-2):92-6. PubMed ID: 10428479
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Structure/function analysis of human cystatin SN and comparison of the cysteine proteinase inhibitory profiles of human cystatins C and SN.
    Hiltke TR, Lee TC, Bobek LA.
    J Dent Res; 1999 Aug 16; 78(8):1401-9. PubMed ID: 10439027
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hybrids of chicken cystatin with human kininogen domain 2 sequences exhibit novel inhibition of calpain, improved inhibition of actinidin and impaired inhibition of papain, cathepsin L and cathepsin B.
    Auerswald EA, Nägler DK, Gross S, Assfalg-Machleidt I, Stubbs MT, Eckerskorn C, Machleidt W, Fritz H.
    Eur J Biochem; 1996 Feb 01; 235(3):534-42. PubMed ID: 8654398
    [Abstract] [Full Text] [Related]

  • 18. Probing the functional role of the N-terminal region of cystatins by equilibrium and kinetic studies of the binding of Gly-11 variants of recombinant human cystatin C to target proteinases.
    Björk I, Brieditis I, Abrahamson M.
    Biochem J; 1995 Mar 01; 306 ( Pt 2)(Pt 2):513-8. PubMed ID: 7887904
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Conserved cystatin segments as models for designing specific substrates and inhibitors of cysteine proteinases.
    Lalmanach G, Serveau C, Brillard-Bourdet M, Chagas JR, Mayer R, Juliano L, Gauthier F.
    J Protein Chem; 1995 Nov 01; 14(8):645-53. PubMed ID: 8747425
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.